User profiles for R. L. Boudreau

Ryan L. Boudreau

University of Iowa - Abboud Cardiovascular Research Center, Iowa Neuroscience Institute
Verified email at uiowa.edu
Cited by 4977

Artificial miRNAs mitigate shRNA-mediated toxicity in the brain: implications for the therapeutic development of RNAi

JL McBride, RL Boudreau, SQ Harper… - Proceedings of the …, 2008 - National Acad Sciences
Huntington's disease (HD) is a fatal, dominant neurodegenerative disease caused by a
polyglutamine repeat expansion in exon 1 of the HD gene, which encodes the huntingtin protein. …

RNAi medicine for the brain: progresses and challenges

RL Boudreau, E Rodríguez-Lebrón… - Human molecular …, 2011 - academic.oup.com
RNAi interference (RNAi) is a powerful gene silencing technology that has immense
potential for treating a vast array of human ailments, for which suppressing disease-associated …

[HTML][HTML] Artificial microRNAs as siRNA shuttles: improved safety as compared to shRNAs in vitro and in vivo

RL Boudreau, I Martins, BL Davidson - Molecular Therapy, 2009 - cell.com
RNA interference (RNAi) provides a promising therapeutic approach to human diseases.
However, data from recent reports demonstrate that short-hairpin RNAs (shRNAs) may cause …

[HTML][HTML] Nonallele-specific silencing of mutant and wild-type huntingtin demonstrates therapeutic efficacy in Huntington's disease mice

RL Boudreau, JL McBride, I Martins, S Shen, Y Xing… - Molecular Therapy, 2009 - cell.com
Huntington's disease (HD) is a fatal neurodegenerative disease caused by mutant huntingtin
(htt) protein, and there are currently no effective treatments. Recently, we and others …

[HTML][HTML] Preclinical safety of RNAi-mediated HTT suppression in the rhesus macaque as a potential therapy for Huntington's disease

JL McBride, MR Pitzer, RL Boudreau, B Dufour… - Molecular Therapy, 2011 - cell.com
To date, a therapy for Huntington's disease (HD), a genetic, neurodegenerative disorder,
remains elusive. HD is characterized by cell loss in the basal ganglia, with particular damage to …

[PDF][PDF] Transcriptome-wide discovery of microRNA binding sites in human brain

RL Boudreau, P Jiang, BL Gilmore, RM Spengler… - Neuron, 2014 - cell.com
The orchestration of brain function requires complex gene regulatory networks that are
modulated, in part, by microRNAs (miRNAs). These noncoding RNAs associate with argonaute (…

Silencing of CDK5 reduces neurofibrillary tangles in transgenic alzheimer's mice

…, B Obara, BS Manjunath, RL Boudreau… - Journal of …, 2010 - Soc Neuroscience
Alzheimer's disease is a major cause of dementia for which treatments remain unsatisfactory.
Cyclin-dependent kinase 5 (CDK5) is a relevant kinase that has been hypothesized to …

[PDF][PDF] Mitoregulin: a lncRNA-encoded microprotein that supports mitochondrial supercomplexes and respiratory efficiency

…, NH Witmer, EJ Anderson, JW Elrod, RL Boudreau - Cell reports, 2018 - cell.com
Mitochondria are composed of many small proteins that control protein synthesis, complex
assembly, metabolism, and ion and reactive oxygen species (ROS) handling. We show that a …

Inhibition of MCU forces extramitochondrial adaptations governing physiological and pathological stress responses in heart

…, RM Weiss, L Yu, RL Boudreau… - Proceedings of the …, 2015 - National Acad Sciences
Myocardial mitochondrial Ca 2+ entry enables physiological stress responses but in excess
promotes injury and death. However, tissue-specific in vivo systems for testing the role of …

Minimizing variables among hairpin-based RNAi vectors reveals the potency of shRNAs

RL Boudreau, AM Monteys, BL Davidson - Rna, 2008 - rnajournal.cshlp.org
RNA interference (RNAi) is a cellular process regulating gene expression and participating
in innate defense in many organisms. RNAi has also been utilized as a tool to query gene …